BioAdaptives Inc (BDPT)

[DD_dempsey]

$BDPT- DD on PATENTS …

CURRENTLY REVIEWING THE PATENT DD- READ BELOW : and it appears better then I initially thought. They are already licensing and product placing. But what I just discovered - is that they are also in process of purchasing those Patents for IP also. I’m trying to confirm if that have negotiated that out already. But that is massive IMO

RIGHTS TO USE- - 1- Additionally, the company acquired patent rights to a method to embed oxygen in water and is developing commercial products based on this technology that will augment and complement our current product lines.

RIGHT TO USE-
In February 2022, the Company acquired US Patent rights to a process that increases dissolved oxygen in water. The process produces MorO2, ingestion of which is believed to increase diffusion of oxygen into muscle tissues. The Company is developing a business plan to manufacture and market products based on the MorO2 technology.

ACQUIRE /OPTION to PURCHASE
2- Effective February 2, 2022, the Company acquired the option to purchase U.S. Patent No. 9,783,432B (the “Patent”), covering technology used in enhancing the capability of water to hold significantly larger amounts of oxygen. Since June 6, 2022, we entered into a services agreement with Wildpack Beverages in Las Vegas, Nevada to co-pack a pilot run (1333 cases) of this Product.

FROM THE 10K-

Effective February 2, 2022, the Company acquired the exclusive option to purchase U.S. Patent No. 9,783,432B (the “Patent”), covering technology used in enhancing the capability of water to hold significantly larger amounts of oxygen. The Agreement also allows the Company a two-year license to use the technology covered by the Patent, including for further development of oxygenated water products for consumers. The Agreement is more fully discussed in the Company’s Form 8-K filed on February 6, 2022. The Company intends to develop consumer products using the oxygenation technology, and has formed a wholly-owned subsidiary, MORO2, Inc. to conduct these activities.

AND NOW LETS LOOK AT THAT 8K - on the SEC EDGAR- $400k Option price!

Effective February 2, 2022, the Company entered into a Patent Purchase Agreement and Consulting Agreement with Thomas J. Mohr. Under the Agreement, the Company has the exclusive option to purchase Mohr’s U.S. Patent No. 9,783,432B (the “Patent”), which covers technology used in enhancing the capability of water to hold significantly larger amounts of oxygen, for a two-year period. The option price is $400,000

. The Agreement furthermore allows the Company a two-year license to use the technology covered by the Patent, including for further development of oxygenated water products for consumers. In exchange for the license, the Company will pay Mohr a royalty, scaled to total product sales.

The Agreement also calls for Mohr to provide consultant/inventor services to the Company during the option period, which may include establishing a research laboratory and prototype manufacturing facility. Among other things, Mohr will assist the Company in developing additional consumer products using the oxygenation technology and provide technical services for manufacture, installation, and use of production machinery. Mohr will be paid a monthly cash stipend. In addition, Mohr allows the Company rights as to inventions created during the Agreement.

The Company will exploit the Patent and Mohr’s consulting services through a newly established wholly-owned subsidiary, MORO2, Inc.

READ THE 8K and PATENT PURCHASE AGREEMENT HERE :
https://www.otcmarkets.com/filing/html?id=15529463&guid=WZT-kWlPRuohOrh


The patents info:
https://patents.justia.com/inventor/yaguang-liu

THAT IS VERY INTRIGUING and I’m currently in process of confirming the later OPTION TO PURCHASE THE PATENT. Imo- that increases the valuation here substantially. But First we need Confirmation.